COVID-19 AND CHRONIC INFLAMMATORY RHEUMATISM: RESULTS OF A SINGLE CENTER STUDY

被引：0

作者：

Bahaz, N. ^{[1
]}

Mechid, F. ^{[1
]}

Benaziez, R. ^{[1
]}

Zehraoui, N. ^{[1
]}

Hafirassou, H. ^{[1
]}

Rahmoune, A. ^{[1
]}

Ferhat, A. ^{[1
]}

Benaziez, S. ^{[1
]}

Sadeg, Y. ^{[1
]}

Dahou-Makhloufi, C. ^{[1
]}

机构：

[1] Mohamed Lamine Debaghine Hosp, Dept Rheumatol, Bab El Oued, Algeria

来源：

OSTEOPOROSIS INTERNATIONAL | 2021年 / 32卷 / SUPPL 1期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

P631

引用

页码：S314 / S314

页数：1

共 2 条

[1] Use of conventional synthetic and biologic disease-modifying anti-rheumatic drugs in patients with rheumatic diseases contracting COVID-19: a single-center experience [J].

Migkos, Michalis P. ;

Kaltsonoudis, Evripidis ;

Pelechas, Eleftherios ;

Drossou, Vassiliki ;

Karagianni, Panagiota G. ;

Kavvadias, Athanasios ;

Voulgari, Paraskevi V. ;

Drosos, Alexandros A. .

RHEUMATOLOGY INTERNATIONAL, 2021, 41 (05) :903-909

[2] Clinical features of rheumatic patients infected with COVID-19 in Wuhan, China [J].

Ye, Cong ;

Cai, Shaozhe ;

Shen, Guifen ;

Guan, Hanxiong ;

Zhou, Liling ;

Hu, Yangyang ;

Tu, Wei ;

Chen, Yu ;

Yu, Yikai ;

Wu, Xuefen ;

Chen, Yuxue ;

Zhong, Jixin ;

Dong, Lingli .

ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (08) :1007-1013

← 1 →